A First-in-human Study of the Effects of SRP-1005 in Participants With Huntington's Disease

计划入组 32 人 · 首次发布于 2026 年 4 月 17 日

SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis

计划入组 80 人 · 首次发布于 2006 年 2 月 27 日

Study to Evaluate SPI-1005 in Adults With Meniere's Disease

计划入组 40 人 · 首次发布于 2015 年 11 月 11 日

SRP-001

SRP-4055

SRP-4050

SRM Entertainment

United States

RESTECH SRL

Italy

POLICHEM SRL

Italy

Sarepta Therapeutics Submits Clinical Trial Application for SRP-1005 Huntington's Disease Treatment

Sarepta Advances SRP-1003 siRNA Therapy for Myotonic Dystrophy Type 1 with Positive Safety Review

South Rampart Pharma's SRP-001 Shows Promise as Non-Opioid Pain Treatment in Phase 1 Trial